Successful treatment of pemphigus foliaceus with rituximab : RReport of 3 cases;Erfolgreiche Therapie des Pemphigus foliaceus mit Rituximab : Bericht über 3 Patienten

Hautarzt

Volumn 60, Issue 9, 2009, Pages 743-748

  Alter, M ^a   Wittmann, M ^a   Volker B ^a   Kapp, A ^a   Werfel, T ^a   Gutzmer, R ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Autoimmune bullous diseases; Continuation therapy; Pemphigus foliaceus; Rituximab; Therapy

Indexed keywords

AZATHIOPRINE; CALCIUM CARBONATE; CD20 ANTIGEN; CLEMASTINE; COLECALCIFEROL; DAPSONE; DESMOGLEIN 1; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PANTOPRAZOLE; PARACETAMOL; PREDNISOLONE; RITUXIMAB;

ABDOMEN; ADULT; ARTICLE; B LYMPHOCYTE; BACTERIAL SUPERINFECTION; BLISTER; BREAST; CASE REPORT; CATARACT; CONSERVATIVE TREATMENT; CUSHING DISEASE; DISEASE DURATION; DRUG DOSE REDUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA; EXUDATE; FACE; HUMAN; IMMUNOFLUORESCENCE TEST; IMMUNOSUPPRESSIVE TREATMENT; INFECTIOUS COMPLICATION; LIMB; MALE; MULTIPLE CYCLE TREATMENT; OSTEOPOROSIS; PEMPHIGUS FOLIACEUS; PREMEDICATION; REMISSION; SCALP; SHOULDER; SIDE EFFECT; SKIN ATROPHY; SKIN DEFECT; STEROID THERAPY; SYSTEMIC THERAPY; WEIGHT GAIN;

ADULT; ANTIBODIES, MONOCLONAL; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; MALE; MIDDLE AGED; PEMPHIGUS; TREATMENT OUTCOME;

EID: 70149117528     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-008-1682-0     Document Type: Article

References (14)

1. Ahmed A, Spiegelman ZCL, Posner M (2006) Treatment of pemphigus vulgaris with rituximab and intravenous immunglobulin. N Engl J Med 355:1772-1779 (Pubitemid 44631360)
2. Arin MJ, Engert A, Krieg T, Hunzelmann N (2005) Anti-CD20 monoclonal antibody (rituximab) in the treatment of pemphigus. Br J Dermatol 153:620-625
3. Cianchini G, Corona R, Frezzolini A et al (2007) Treatment of severe pemphigus with rituximab: report of 12 cases and a review of the literature. Arch Dermatol 143:1033-1038
4. Fatourechi MM, el Azhary RA, Gibson LE (2006) Rituximab: applications in dermatology. Int J Dermatol 45:1143-1155
5. Goebeler M, Herzog S, Broecker EB, Zillikens D (2003) Rapid response of treatment-resistant pemphigus foliaceus to the anti-CD20 antibody rituximab. Br J Dermatol 149:899-901
6. Goh M, McCormack C, Dinh H et al (2007) Rituxi-mab in adjuvant treatment of peemphigus vulgaris: a prospective open-label pilot study in five patients. Br J Dermatol 156:990-996
7. Hertl M, Zillikens D, Borradori L et al (2008) Emp-fehlungen für den Einsatz von Rituximab (anti-CD-20-Antikörper) bei bullösen Autoimmundermatosen. JDDG 6:366-374
8. Joly P, Mouquet H, Roujeau JC et al (2007) A single cycle of rituximab for the treatment of severe pemphigus. N Engl J Med 357:545-552
9. Kasperkiewicz M, Zillikens D (2007) Rituximab (an-ti-CD20) for the treatment of autoimmune bullous diseases. Hautarzt 58:115-121
10. Marzano AV, Fanoni D, Venegoni L et al (2007) Treatment of refractory pemphigus with the anti-CD20 monoclonal antibody (rituximab). Dermatology 214:310-318
11. Reff ME, Carner K, Chambers KS et al (1994) Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood 83:435-445
12. Schmidt E, Hunzelmann N, Zillikens D et al (2006) Rituximab in autoimmune diseases. Clin Exp Dermatol 31:503-508
13. Shimanovich I, Nitschke M, Rose C et al (2008) Treatment of severe pemphigus with protein A immunoadsorbtion, rituximab and intravenous immunoglobulins. Br J Dermatol 158:382-388
14. Stashenko P, Nadler LM, Hardy R, Schlossman SF (1980) Characterization of a human B lymphocyte-specific antigen. J Immunol 125:1678-1685